Two Sigma Investments, LP Kintara Therapeutics, Inc. Transaction History

Two Sigma Investments, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$0.31 - $0.55 $10,733 - $19,043	-34,624 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$0.51 - $1.04 $10,016 - $20,425	-19,640 Reduced 36.19%	34,624 $18,000
Q3 2021 Nov 15, 2021	BUY	$0.82 - $2.3 $44,496 - $124,807	54,264 New	54,264 $47,000
Q1 2021 May 17, 2021	SELL	$1.32 - $2.74 $23,059 - $47,865	-17,469 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$1.26 - $1.72 $3,940 - $5,378	-3,127 Reduced 15.18%	17,469 $22,000
Q3 2020 Nov 16, 2020	BUY	$0.63 - $1.7 $12,975 - $35,013	20,596 New	20,596 $29,000

Ticker KTRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,807,296
Market Cap $17.8M
Description
Kintara Therapeutics, Inc., a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients. It is developing two late-stage, Phase III-ready therapeutics, including VAL-083, a DNA-targeting agent for the treatment of drug-resistant solid tumors, such as glioblastoma multiforme,...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.